Peritoneal dialysis

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Peritoneal dialysis.php on line 2
Peritoneal dialysis

LE WE PMID CA

Peritoneal dialysis

2158

Peritonealdialyse

AQP1

CA125

Claudin

Cough

Encapsulating peritoneal sclerosis

Heart failure (chronical)

Icodextrin

Mesenterial ischemia

Peritoneal dialysis

Peritoneum (Anatomy)

Peritoneum (Peritonitis)

2007 1	Noninfectious complications of peritoneal dialysis. [17269526] South Med J 100(1): 54-8 (2007)
2007 2	Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis. [18162703] J Korean Med Sci 22(6): 943-5 (2007)
1985 3	The efficacy and adequacy of continuous ambulatory peritoneal dialysis. [3909582] Ulster Med J 54 Suppl(-): S48-61 (1985)
2006 4	Protecting the peritoneal membrane in dialyzed patients. [17357307] Adv Med Sci 51(-): 191-6 (2006)
2009 5	The Dutch EPS Registry: increasing the knowledge of encapsulating peritoneal sclerosis. [19767668] Neth J Med 67(8): 359-62 (2009)
2008 6	Encapsulating peritoneal sclerosis in patients on peritoneal dialysis. [18663253] Neth J Med 66(7): 269-74 (2008)
2006 7	Peritoneal dialysis: a primary care perspective. [16809653] J Am Board Fam Med 19(4): 380-9 (2006)
1992 8	Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis. [1735094] Clin Microbiol Rev 5(1): 36-48 (1992)
2007 9	New technologies in peritoneal dialysis. [17699465] Clin J Am Soc Nephrol 2(3): 576-80 (2007)
2004 10	The surgical management of peritoneal dialysis catheters. [15140305] Ann R Coll Surg Engl 86(3): 190-5 (2004)
2009 11	Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. [19670954] Am J Manag Care 15(8): 509-18 (2009)
1977 12	Peritoneal dialysis in children. Review of 8 years' experience. [836055] Arch Dis Child 52(1): 56-61 (1977)
1977 13	The coming of age of home peritoneal dialysis. [837298] Can Med Assoc J 116(3): 232 (1977)
1992 14	Progressive systemic sclerosis complicated with immune thrombocytopenia during D-penicillamine therapy. [1600273] Intern Med 31(2): 244-5 (1992)
2007 15	Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. [17582162] J Am Soc Nephrol 18(7): 2172-9 (2007)
2007 16	Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. [17568021] J Am Soc Nephrol 18(7): 2004-13 (2007)
2006 17	Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. [16885406] J Am Soc Nephrol 17(9): 2591-8 (2006)
2004 18	Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. [15466279] J Am Soc Nephrol 15(10): 2735-46 (2004)
2002 19	Acquired ultrafiltration dysfunction in peritoneal dialysis patients. [12397051] J Am Soc Nephrol 13(11): 2787-94 (2002)
2002 20	Peritoneal dialysis in the 21st century: an analysis of current problems and future developments. [11792770] J Am Soc Nephrol 13 Suppl 1(-): S104-16 (2002)
2002 21	Solute transport across the peritoneal membrane. [11792767] J Am Soc Nephrol 13 Suppl 1(-): S84-91 (2002)
1992 22	Is continuous ambulatory peritoneal dialysis adequate long-term therapy for end-stage renal disease? A critical assessment. [1482746] J Am Soc Nephrol 3(5): 1039-48 (1992)
1991 23	Peritoneal transport physiology: insights from basic research. [1954325] J Am Soc Nephrol 2(2): 122-35 (1991)
1982 24	Laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. [6754760] J Clin Pathol 35(11): 1181-4 (1982)
1994 25	Ultrafiltration failure in CAPD. [8699390] J Postgrad Med 40(3): 185-93 (1994)
1994 26	Connecting devices in CAPD and their impact on peritonitis. [8699389] J Postgrad Med 40(3): 179-84 (1994)
1994 27	Peritoneal access. [8699388] J Postgrad Med 40(3): 170-8 (1994)
2002 28	Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. [11849377] Kidney Int 61(2): 375-86 (2002)
2000 29	Peritoneal dialysis adequacy and risk of death. [10886593] Kidney Int 58(1): 446-57 (2000)
2000 30	Tidal peritoneal dialysis: comparison of different tidal regimens and automated peritoneal dialysis. [10844630] Kidney Int 57(6): 2603-7 (2000)
1999 31	The peritoneal membrane in chronic peritoneal dialysis. [9893150] Kidney Int 55(1): 341-56 (1999)
1998 32	What is the place of peritoneal dialysis in the integrated treatment of renal failure? [9853290] Kidney Int 54(6): 2234-40 (1998)
1998 33	Augmenting solute clearance in peritoneal dialysis. [9853288] Kidney Int 54(6): 2218-25 (1998)
1998 34	What really happens to people on long-term peritoneal dialysis? [9853287] Kidney Int 54(6): 2207-17 (1998)
1998 35	Experimental models in peritoneal dialysis: a European experience. [9853286] Kidney Int 54(6): 2194-206 (1998)
1998 36	Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. [9853285] Kidney Int 54(6): 2184-93 (1998)
2006 37	Peritoneal dialysis in patients with congestive heart failure. [16825265] Nephrol Dial Transplant 21 Suppl 2(-): ii63-6 (2006)
2006 38	Peritoneal sclerosis--aetiology, diagnosis, treatment and prevention. [16825259] Nephrol Dial Transplant 21 Suppl 2(-): ii38-41 (2006)
2006 39	Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis. [16825254] Nephrol Dial Transplant 21 Suppl 2(-): ii2-7 (2006)
2005 40	European best practice guidelines for peritoneal dialysis. 3 Peritoneal access. [16263753] Nephrol Dial Transplant 20 Suppl 9(-): ix8-ix12 (2005)
2005 41	European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis. [16263750] Nephrol Dial Transplant 20 Suppl 9(-): ix3-ix7 (2005)
2005 42	European best practice guidelines for peritoneal dialysis. 8 Nutrition in peritoneal dialysis. [16263749] Nephrol Dial Transplant 20 Suppl 9(-): ix28-ix33 (2005)
2005 43	European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. [16263748] Nephrol Dial Transplant 20 Suppl 9(-): ix24-ix27 (2005)
2005 44	European best practice guidelines for peritoneal dialysis. 6 Automated peritoneal dialysis. [16263747] Nephrol Dial Transplant 20 Suppl 9(-): ix21-ix23 (2005)
2005 45	European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions. [16263745] Nephrol Dial Transplant 20 Suppl 9(-): ix16-ix20 (2005)
2005 46	European best practice guidelines for peritoneal dialysis. 4 Continuous ambulatory peritoneal dialysis delivery systems. [16263744] Nephrol Dial Transplant 20 Suppl 9(-): ix13-ix15 (2005)
2002 47	Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions. [11912293] Nephrol Dial Transplant 17 Suppl 3(-): 12-5 (2002)
2000 48	Peritoneal solute transport--we know it is important, but what is it? [10910432] Nephrol Dial Transplant 15(8): 1120-3 (2000)
1997 49	Current approach to exit-site infections in patients on peritoneal dialysis. [9198074] Nephrol Dial Transplant 12(6): 1284-95 (1997)
1997 50	Preserving the peritoneum in CAPD. [9075114] Nephrol Dial Transplant 12(3): 393-5 (1997)
2009 51	Rapid solute transport in the peritoneum: physiologic and clinical consequences. [19270240] Perit Dial Int 29 Suppl 2(-): S90-5 (2009)
2009 52	Histology in experimental peritoneal dialysis: the link between structure and function. [19270228] Perit Dial Int 29 Suppl 2(-): S36-9 (2009)
2009 53	Encapsulating peritoneal sclerosis--medical and surgical treatment. [19270221] Perit Dial Int 29 Suppl 2(-): S211-4 (2009)
2009 54	Intrinsic cells: mesothelial cells -- central players in regulating inflammation and resolution. [19270220] Perit Dial Int 29 Suppl 2(-): S21-7 (2009)
2009 55	Update on mechanisms of ultrafiltration failure. [19270200] Perit Dial Int 29 Suppl 2(-): S123-7 (2009)
2009 56	Long-term outcomes in automated peritoneal dialysis: similar or better than in continuous ambulatory peritoneal dialysis? [19270197] Perit Dial Int 29 Suppl 2(-): S111-4 (2009)
2009 57	Patient selection for automated peritoneal dialysis: for whom, when? [19270195] Perit Dial Int 29 Suppl 2(-): S102-7 (2009)
2009 58	Heparin and the peritoneal membrane. [19164247] Perit Dial Int 29(1): 16-9 (2009)
2009 59	Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use. [19164246] Perit Dial Int 29(1): 5-15 (2009)
2008 60	The peritoneum: from histological studies to mesothelial transplant through animal experimentation. [19008542] Perit Dial Int 28 Suppl 5(-): S5-9 (2008)
2008 61	Glucose-induced mesothelial cell senescence and peritoneal neoangiogenesis and fibrosis. [19008538] Perit Dial Int 28 Suppl 5(-): S34-7 (2008)
2008 62	Experimental encapsulating peritoneal sclerosis models: pathogenesis and treatment. [19008535] Perit Dial Int 28 Suppl 5(-): S21-8 (2008)
2008 63	Pathogenesis and treatment of encapsulating peritoneal sclerosis: basic and translational research. [19008533] Perit Dial Int 28 Suppl 5(-): S10-5 (2008)
2008 64	Claudin tight junction proteins: novel aspects in paracellular transport. [18981384] Perit Dial Int 28(6): 577-84 (2008)
2008 65	An analysis of methods to prevent peritoneal dialysis catheter infections. [18708532] Perit Dial Int 28(5): 437-43 (2008)
2008 66	New insights into the physiology of peritoneal fluid transport. [18552245] Perit Dial Int 28 Suppl 3(-): S144-9 (2008)
2008 67	Quantification of peritoneal transport. [18552244] Perit Dial Int 28 Suppl 3(-): S139-43 (2008)
2008 68	The critical importance of good peritoneal catheter placement. [18496930] Perit Dial Int 28(2): 111-2 (2008)
2008 69	Laparoscopic placement of Tenckhoff catheters for peritoneal dialysis: a safe, effective, and reproducible procedure. [18332453] Perit Dial Int 28(2): 170-3 (2008)
2008 70	Peritoneal dialysis in the comprehensive management of end-stage renal disease patients with liver cirrhosis and ascites: practical aspects and review of the literature. [18332443] Perit Dial Int 28(2): 118-22 (2008)
2008 71	Renal replacement therapy in end-stage renal disease patients with chronic liver disease and ascites: role of peritoneal dialysis. [18332442] Perit Dial Int 28(2): 113-7 (2008)
2008 72	Challenging the three-pore model. [18396505] Perit Dial Int 28(1): 3-4 (2008)
2008 73	Endothelial glycocalyx and the peritoneal barrier. [18178940] Perit Dial Int 28(1): 6-12 (2008)
2007 74	Peritoneal transport kinetics with amino acid-based and glucose-based peritoneal dialysis solutions. [17704439] Perit Dial Int 27(5): 518-22 (2007)
2007 75	Achieving euvolemia in peritoneal dialysis. [17704438] Perit Dial Int 27(5): 514-7 (2007)
2007 76	Peritoneal proteoglycans: much more than ground substance. [17602143] Perit Dial Int 27(4): 375-90 (2007)
2007 77	Studying the effects of new peritoneal dialysis solutions on the peritoneum. [17556337] Perit Dial Int 27 Suppl 2(-): S87-93 (2007)
2007 78	Peritoneal fibrosis intervention. [17556336] Perit Dial Int 27 Suppl 2(-): S82-6 (2007)
2007 79	In vitro study of peritoneal fibrosis. [17556334] Perit Dial Int 27 Suppl 2(-): S72-5 (2007)
2007 80	Encapsulating peritoneal sclerosis: prevention and treatment. [17556321] Perit Dial Int 27 Suppl 2(-): S289-92 (2007)
2007 81	Long-term peritoneal dialysis in infants. [17556301] Perit Dial Int 27 Suppl 2(-): S180-4 (2007)
2007 82	Methodology of assessment of fluid status and ultrafiltration problems. [17556293] Perit Dial Int 27 Suppl 2(-): S143-7 (2007)
2007 83	Rational choice of peritoneal dialysis catheter. [17556289] Perit Dial Int 27 Suppl 2(-): S119-25 (2007)
2007 84	Mesothelial cells. [17556288] Perit Dial Int 27 Suppl 2(-): S110-5 (2007)
2007 85	Agents that modulate peritoneal membrane structure and function. [17179504] Perit Dial Int 27(1): 16-30 (2007)
2006 86	Animal models in peritoneal dialysis: a story of kangaroos and ostriches. [16973512] Perit Dial Int 26(5): 571-3 (2006)
2006 87	Peritoneal mesothelial cell culture and biology. [16623418] Perit Dial Int 26(2): 162-73 (2006)
2005 88	Measurement of protein glycation, glycated peptides, and glycation free adducts. [16419322] Perit Dial Int 25(6): 522-33 (2005)
2005 89	Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. [16300277] Perit Dial Int 25 Suppl 4(-): S83-95 (2005)
2005 90	The role of peritoneal fibrosis in encapsulating peritoneal sclerosis. [16300272] Perit Dial Int 25 Suppl 4(-): S48-56 (2005)
2005 91	Successful surgical management of encapsulating peritoneal sclerosis. [16300271] Perit Dial Int 25 Suppl 4(-): S39-47 (2005)
2005 92	Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment. [16300270] Perit Dial Int 25 Suppl 4(-): S30-8 (2005)
2005 93	A historical review of encapsulating peritoneal sclerosis. [16300267] Perit Dial Int 25 Suppl 4(-): S7-13 (2005)
2005 94	Therapeutic dilemmas in the management of peritonitis. [15796142] Perit Dial Int 25(2): 152-6 (2005)
2005 95	Sterile peritonitis in the peritoneal dialysis patient. [15796141] Perit Dial Int 25(2): 146-51 (2005)
2005 96	Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments. [15796138] Perit Dial Int 25(2): 132-9 (2005)
2005 97	The influence of peritoneal surface area on dialysis adequacy. [16048280] Perit Dial Int 25 Suppl 3(-): S137-40 (2005)
2005 98	Individualized PD prescription: APD versus CAPD. [16048267] Perit Dial Int 25 Suppl 3(-): S92-4 (2005)
2005 99	Animal models in peritoneal dialysis research: a need for consensus. [15770920] Perit Dial Int 25(1): 16-24 (2005)
2004 100	Ultrafiltration failure in peritoneal dialysis patients. [15559474] Perit Dial Int 24(6): 506-8 (2004)
2003 101	Basic mechanisms and clinical implications of peritoneal fibrosis. [14703193] Perit Dial Int 23(6): 530-41 (2003)
2001 102	What happens to the peritoneal membrane in long-term peritoneal dialysis? [11887871] Perit Dial Int 21 Suppl 3(-): S9-18 (2001)
2001 103	Peritoneal dialysis solutions. [11887870] Perit Dial Int 21 Suppl 3(-): S89-95 (2001)
2001 104	Peritoneal access in children. [11887825] Perit Dial Int 21 Suppl 3(-): S218-22 (2001)
2000 105	Recommended peritoneal dialysis curriculum for nephrology trainees. The International Society for Peritoneal Dialysis (ISPD) Standards and Education Subcommittee. [11117240] Perit Dial Int 20(5): 497-502 (2000)
2000 106	Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. [11098926] Perit Dial Int 20 Suppl 4(-): S5-21 (2000)
2000 107	Management of high peritoneal transporters. [10911663] Perit Dial Int 20 Suppl 2(-): S160-5 (2000)
2000 108	Advantages of tidal peritoneal dialysis. [10911652] Perit Dial Int 20 Suppl 2(-): S98-100 (2000)
2000 109	Continuous cycling peritoneal dialysis, PD plus, and high-flow automated peritoneal dialysis: a spectrum of therapies. [10911651] Perit Dial Int 20 Suppl 2(-): S93-7 (2000)
2000 110	Creatinine is the best molecule to target adequacy of peritoneal dialysis. [10911646] Perit Dial Int 20 Suppl 2(-): S65-9 (2000)
2000 111	Urea is the best molecule to target adequacy of peritoneal dialysis. [10911645] Perit Dial Int 20 Suppl 2(-): S58-64 (2000)
2000 112	Chemistry of glucose and biochemical pathways of biological interest. [10911639] Perit Dial Int 20 Suppl 2(-): S26-30 (2000)
2000 113	Neoangiogenesis in the peritoneal membrane. [10911638] Perit Dial Int 20 Suppl 2(-): S19-25 (2000)
2000 114	Effect of high glucose on peritoneal mesothelial cell biology. [10911637] Perit Dial Int 20 Suppl 2(-): S15-8 (2000)
1999 115	Effect of peritoneal dialysis on peritoneal macrophages. [10406544] Perit Dial Int 19 Suppl 2(-): S343-7 (1999)
1999 116	The effect of various dialysis solutions on peritoneal membrane viability. [10406529] Perit Dial Int 19 Suppl 2(-): S257-66 (1999)
1999 117	Impact of peritoneal membrane function on long-term clinical outcome in peritoneal dialysis patients. [10406500] Perit Dial Int 19 Suppl 2(-): S91-4 (1999)
1999 118	Changes in the peritoneal interstitium and their effect on peritoneal transport. [10406498] Perit Dial Int 19 Suppl 2(-): S77-82 (1999)
1999 119	Pathogenic role of advanced glycation end-products (AGEs): an overview. [10406493] Perit Dial Int 19 Suppl 2(-): S47-52 (1999)
1997 120	What is the problem with high transporters? [9284454] Perit Dial Int 17(4): 317-20 (1997)
1997 121	Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. [9159834] Perit Dial Int 17(2): 144-50 (1997)
1997 122	The peritoneal dialysis system: importance of each component. [9163806] Perit Dial Int 17 Suppl 2(-): S91-7 (1997)
1997 123	Glycation and advanced glycation end-product formation with icodextrin and dextrose. [9068023] Perit Dial Int 17(1): 52-8 (1997)
1997 124	Icodextrin's effects on peritoneal transport. [9068020] Perit Dial Int 17(1): 35-41 (1997)
1997 125	Icodextrin: overview of clinical experience. [9068018] Perit Dial Int 17(1): 22-6 (1997)
1997 126	Recent developments in peritoneal dialysis solutions. [9068014] Perit Dial Int 17(1): 9-10 (1997)
1996 127	The "nearest capillary" hypothesis: a novel approach to peritoneal transport physiology. [9147543] Perit Dial Int 16(2): 121-5 (1996)
1996 128	Exit-site study methods and results. [8860148] Perit Dial Int 16 Suppl 3(-): S6-S31 (1996)
1996 129	Peritoneal equilibration in children. [8728264] Perit Dial Int 16 Suppl 1(-): S532-9 (1996)
1996 130	The peritoneal access. [8728216] Perit Dial Int 16 Suppl 1(-): S322-6 (1996)
1996 131	Implantation techniques for peritoneal dialysis catheters. [8728215] Perit Dial Int 16 Suppl 1(-): S319-21 (1996)
1996 132	Bicarbonate: the alternative buffer for peritoneal dialysis. [8728174] Perit Dial Int 16 Suppl 1(-): S109-13 (1996)
1996 133	Optimal use of glucose polymer (icodextrin) in peritoneal dialysis. [8728173] Perit Dial Int 16 Suppl 1(-): S104-8 (1996)
1996 134	Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent? [8728172] Perit Dial Int 16 Suppl 1(-): S97-103 (1996)
1996 135	The importance of the interstitium in peritoneal transport. [8728167] Perit Dial Int 16 Suppl 1(-): S76-9 (1996)
1996 136	Peritoneal blood flow: does it matter? [8728166] Perit Dial Int 16 Suppl 1(-): S70-5 (1996)
1996 137	Markers of peritoneal membrane status. [8728161] Perit Dial Int 16 Suppl 1(-): S42-9 (1996)
1996 138	CAPD overview. [8728156] Perit Dial Int 16 Suppl 1(-): S13-8 (1996)
1995 139	The biology of the mesothelium during peritoneal dialysis. [8555322] Perit Dial Int 15(7 Suppl): S13-22; discussion S22-3 (1995)
1994 140	Peritoneal dialysis in infants, children, and adolescents. [8312412] Perit Dial Int 14(1): 4-6 (1994)
1994 141	Treatment of peritonitis. [7948276] Perit Dial Int 14 Suppl 3(-): S49-55 (1994)
1994 142	Bidirectional solute transport in peritoneal dialysis. [7827181] Perit Dial Int 14(4): 327-37 (1994)
1994 143	Technique survival in continuous ambulatory peritoneal dialysis. [7827179] Perit Dial Int 14(4): 322-3 (1994)
1993 144	In search of a role for submesothelial fenestrated capillaries. [8494949] Perit Dial Int 13(2): 98-102 (1993)
1993 145	Biocompatibility of peritoneal dialysis solutions. [8494947] Perit Dial Int 13(2): 88-94 (1993)
1993 146	Ultrafiltration failure in continuous ambulatory peritoneal dialysis. [8399673] Perit Dial Int 13 Suppl 2(-): S59-66 (1993)
1993 147	Continuous ambulatory peritoneal dialysis connection systems. [8399550] Perit Dial Int 13 Suppl 2(-): S139-45 (1993)
1992 148	Peritoneal dialysis catheter connection devices: what have we learned? [1543792] Perit Dial Int 12(1): 9-11 (1992)
1992 149	Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. [1347465] Perit Dial Int 12(1): 14-27 (1992)
1991 150	Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 1. [2049417] Perit Dial Int 11(1): 14-21 (1991)
1991 151	Exit-site infection in continuous ambulatory peritoneal dialysis: a review. [1751600] Perit Dial Int 11(4): 333-40 (1991)
1990 152	Pharmacologic modification of transperitoneal movement of water. [2096931] Perit Dial Int 10(4): 291-4 (1990)
1990 153	Pathophysiology of ultrafiltration in peritoneal dialysis. [2085596] Perit Dial Int 10(2): 119-26 (1990)
1989 154	The peritoneal mesothelium: an excretory organ. [2488359] Perit Dial Int 9(3): 151-3 (1989)
1991 155	Sodium and potassium in red blood cells of premature infants during the first few days: risk of hyperkalaemia. [1755294] Acta Paediatr Scand 80(10): 899-904 (1991)
1977 156	[Research in maternal and child health and in human reproduction]. [872816] Educ Med Salud 11(1): 41-9 (1977)
1975 157	Episodic secretion of renin. [1109898] Endocrinology 96(1): 129-34 (1975)
1976 158	[Changes in the oxygen tension of rat cerebral cortex subsequent to hyperoxia and the protective effect of urea]. [955149] Fiziol Zh SSSR Im I M Sechenova 62(7): 1062-7 (1976)
1994 159	Peritoneal dialysis. [8007595] Kidney Int 45(4): 1226-40 (1994)
1983 160	Microbiologic aspects of chronic ambulatory peritoneal dialysis. [6339790] Kidney Int 23(1): 83-92 (1983)
1991 161	[Blood gas changes induced by peridural anesthesia in geriatric patients]. [1798442] Minerva Anestesiol 57(9): 466-7 (1991)
1990 162	[From the circulating renin-angiotensin system to the intratissular renin-angiotensin systems. A complex relationship stage]. [1964249] Therapie 45(6): 489-97 (1990)
2005 163	The transport barrier in intraperitoneal therapy. [15692055] Am J Physiol Renal Physiol 288(3): F433-42 (2005)
2009 164	Complications of continuous ambulatory peritoneal dialysis. [19325058] Radiographics 29(2): 441-60 (2009)
2010 165	Imaging features of encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. [20566781] AJR Am J Roentgenol 195(1): W50-4 (2010)
2010 166	The pathophysiology of the peritoneal membrane. [20448020] J Am Soc Nephrol 21(7): 1077-85 (2010)
2002 167	New insights in the molecular mechanisms regulating peritoneal permeability. [11917043] Nephrol Dial Transplant 17(4): 548-51 (2002)
2006 168	Estimates of peritoneal membrane function--new insights. [16825253] Nephrol Dial Transplant 21 Suppl 2(-): ii16-9 (2006)
2010 169	Dialysis-associated peritonitis in children. [19190935] Pediatr Nephrol 25(3): 425-40 (2010)
2010 170	Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children. [21476232] Pediatr Nephrol 25(1): 75-81 (2010)
2009 171	Selection of modalities, prescription, and technical issues in children on peritoneal dialysis. [18521632] Pediatr Nephrol 24(8): 1453-64 (2009)
2009 172	Peritoneal dialysis prescription in children: bedside principles for optimal practice. [18807074] Pediatr Nephrol 24(9): 1633-42; quiz 1640, 1642 (2009)
2006 173	Peritoneal dialysis and cough: ACCP evidence-based clinical practice guidelines. [16428711] Chest 129(1 Suppl): 202S-203S (2006)
2006 174	Surgical complications of Tenckhoff catheters used in continuous ambulatory peritoneal dialysis. [16865213] Singapore Med J 47(8): 707-11 (2006)
2010 175	Peritoneal adipocytes and their role in inflammation during peritoneal dialysis. [20454534] Mediators Inflamm 2010(-): 495416 (2010)
2010 176	Strategies for improving long-term survival in peritoneal dialysis patients. [20430945] Clin J Am Soc Nephrol 5(6): 1123-31 (2010)
2010 177	Biocompatible peritoneal dialysis solutions: do we have one? [20093342] Clin J Am Soc Nephrol 5(4): 723-32 (2010)
2011 178	Outcome and complications in peritoneal dialysis patients: a five-year single center experience. [21422621] Saudi J Kidney Dis Transpl 22(2): 245-51 (2011)
2003 179	Cancer Antigen (CA) 125, a Novel Peritoneal Membrane Marker in CAPD Patients. [17657117] Saudi J Kidney Dis Transpl 14(4): 462-8 (2003)
2009 180	Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment. [20010468] Pol Arch Med Wewn 119(12): 815-9 (2009)
2010 181	Peritoneal transport testing. [20540028] J Nephrol 23(6): 633-47 (2010)
2009 182	Reducing cardiometabolic risk in peritoneal dialysis patients: role of the dialysis solution. [20144403] J Diabetes Sci Technol 3(6): 1472-80 (2009)
2010 183	Peritonitis and catheter guidelines--a 2010 update. [21815290] Perit Dial Int 30(4): 391-2 (2010)
2010 184	Clinical practice guidelines for peritoneal access. [20628103] Perit Dial Int 30(4): 424-9 (2010)
2002 185	Abdominal catastrophe revisited: the risk and outcome of enteric peritoneal contamination. [12227389] Perit Dial Int 22(3): 323-34 (2002)
2010 186	Aquaporin-1: new developments and perspectives for peritoneal dialysis. [20200365] Perit Dial Int 30(2): 135-41 (2010)
2010 187	The remarkable interface between aquaporins and peritoneal dialysis. [21485433] Perit Dial Int 30(2): 131-2 (2010)
2008 188	How can genetic advances impact on experimental models of encapsulating peritoneal sclerosis? [19008534] Perit Dial Int 28 Suppl 5(-): S16-20 (2008)
2007 189	The John F. Maher Award Recipient Lecture 2006. The "heart" of peritoneal dialysis: residual renal function. [17299143] Perit Dial Int 27(2): 116-24 (2007)
2007 190	Nonocclusive mesenteric ischemia: a lethal complication in peritoneal dialysis patients. [17299146] Perit Dial Int 27(2): 136-41 (2007)
2009 191	Icodextrin: fifteen years and counting. Introduction. [19725196] Perit Dial Int 29(4): 367-9 (2009)
2009 192	Novel approaches to prescribing icodextrin. [19602606] Perit Dial Int 29(4): 412-4 (2009)
2009 193	Icodextrin metabolites in peritoneal dialysis. [19602601] Perit Dial Int 29(4): 370-6 (2009)
2009 194	Understanding the variability in ultrafiltration obtained with icodextrin. [19602605] Perit Dial Int 29(4): 407-11 (2009)
2011 195	Vascular and valvular calcification in chronic peritoneal dialysis patients. [21826268] Int J Nephrol 2011(-): 198045 (2011)
2011 196	Peritoneal Dialysis Drop-out: Causes and Prevention Strategies. [22121484] Int J Nephrol 2011(-): 434608 (2011)
2010 197	Can we reduce the cardiovascular risk in peritoneal dialysis patients? [20835317] Indian J Nephrol 20(2): 59-67 (2010)
2011 198	Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data. [20449655] Int Urol Nephrol 43(1): 147-56 (2011)
2010 199	Risk factors associated with peritoneal dialysis catheter survival: a 9-year single-center study in 315 patients. [20890875] J Vasc Access 11(4): 316-22 (2010)
2007 200	Laparoscopic peritoneal dialysis catheter insertion using a Quinton percutaneous insertion kit. [17761082] JSLS 11(2): 208-14 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Peritoneal dialysis.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Peritoneal dialysis.php on line 92